James Peyer - Feb 18, 2021 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 18, 2021
Transactions value $
$14,852
Form type
4/A - Amendment
Date filed
4/21/2022, 04:22 PM
Date Of Original Report
Feb 19, 2021
Previous filing
Aug 1, 2022
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $14.9K +752 +0.02% $19.75* 4.69M Feb 18, 2021 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the number of shares purchased. The original Form 4 filed on February 19, 2021, overstated the number of shares purchased.
F2 These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian").The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.